12 insiders reported 36 Form 4 transactions for Revance Therapeutics, Inc. (RVNC) over the past 18 months (most recent 2025-02-06). Recent activity: Gangolli Julian S (Director) Sell 15,000 shares, Schilke Tobin (CFO) Sell 103,555 shares, Nolet Chris (Director) Sell 28,606 shares, Nolet Chris (Director) Sell 15,000 shares, Gangolli Julian S (Director) Sell 30,106 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-06 | Gangolli Julian S | Director | Sell | 15,000 | $0 |
| 2025-02-06 | Schilke Tobin | CFO | Sell | 103,555 | $0 |
| 2025-02-06 | Nolet Chris | Director | Sell | 28,606 | $104,412 |
| 2025-02-06 | Nolet Chris | Director | Sell | 15,000 | $0 |
| 2025-02-06 | Gangolli Julian S | Director | Sell | 30,106 | $109,887 |
| 2025-02-06 | Hollander David | CMO & Global Therapeutics Lead | Sell | 9,733 | $35,525 |
| 2025-02-06 | Russell Angus C. | Director | Sell | 36,506 | $133,247 |
| 2025-02-06 | Foley Mark J | President & CEO | Sell | 27,933 | $0 |
| 2025-02-06 | Jordan Erica | Chief Commercial Officer | Sell | 6,922 | $25,265 |
| 2025-02-06 | Jordan Erica | Chief Commercial Officer | Sell | 107,942 | $0 |
| 2025-02-06 | Beraud Jill | Director | Sell | 28,606 | $104,412 |
| 2025-02-06 | Beraud Jill | Director | Sell | 15,000 | $0 |
| 2025-02-06 | Moxie Dwight | CLO & GC | Sell | 47,815 | $174,525 |
| 2025-02-06 | Moxie Dwight | CLO & GC | Sell | 95,979 | $0 |
| 2025-02-06 | Moxie Dwight | CLO & GC | Buy | 18,125 | $0 |
| 2025-02-06 | Moxie Dwight | CLO & GC | Sell | 18,125 | $0 |
| 2025-02-06 | Coric Vlad | Director | Sell | 5,784 | $21,112 |
| 2025-02-06 | Coric Vlad | Director | Sell | 15,000 | $0 |
| 2025-02-06 | Schilke Tobin | CFO | Sell | 97,999 | $357,696 |
| 2025-02-06 | Hollander David | CMO & Global Therapeutics Lead | Sell | 95,212 | $0 |
| 2025-02-06 | Schilke Tobin | CFO | Buy | 20,883 | $0 |
| 2025-02-06 | Schilke Tobin | CFO | Sell | 20,883 | $0 |
| 2025-02-06 | Foley Mark J | President & CEO | Sell | 996,935 | $3.6M |
| 2025-02-06 | Foley Mark J | President & CEO | Sell | 110,913 | $404,832 |
| 2025-02-06 | Russell Angus C. | Director | Sell | 15,000 | $0 |
Source: SEC Form 4 filings · as of 2025-02-06
